Results 61 to 70 of about 1,643,766 (139)

Myasthenia Gravis and Thymoma

Muscle &Nerve, Volume 74, Issue 4, Page 1156-1173, October 2026.
ABSTRACT Thymoma is the most common tumor of the anterior mediastinum. Approximately 20%–30% of patients with a thymoma develop myasthenia gravis (MG), and an additional one third may possess positive acetylcholine receptor (AChR) antibodies without MG.
Benjamin Claytor, Lukas Delasos, Daniel P. Raymond, Erik Seroogy, Jason Lempel, Yuebing Li   +5 more
wiley   +1 more source

Cholinesterase deficiency and anesthesia management: Clinical challenges and coping strategies

Journal of Family Medicine and Primary Care
Cholinesterase deficiency is a rare genetic disorder that impairs the activity of acetylcholinesterase and butyrylcholinesterase. It causes severe perioperative risks due to prolonged neuromuscular blockade induced by succinylcholine and ester-based ...
Tiantian Liu, Chaofeng Sun, Song Ye, Qinsong Ye, Ding Li   +4 more
doaj   +1 more source

Perioperative Adverse Events in Primary Palatoplasty: “Risk Factors and Impact on Care Escalation in a Multicenter Cohort”

Pediatric Anesthesia, Volume 36, Issue 10, Page 1247-1253, October 2026.
ABSTRACT Background Patients undergoing palatoplasty experience perioperative adverse events. Identifying risk factors for perioperative adverse events and escalation of care may improve outcomes. Methods Pediatric patients undergoing primary palatoplasty were included in this retrospective observational study performed at two academic children's ...
Febina Padiyath, Elizabeth M. O'Brien, Jennifer Nam, Paula Hu, Nishil Mehta, Marc Parris, Anthony Alexander, Ashley Hodges, Goretti Chiang, Vinícius Caldeira Quintão, Ricardo Vieira Carlos, Gabriel Soares de Sousa, Asif Padiyath, Susan C. Nicolson, John Fiadjoe, Oksana A. Jackson, Lisa K. Lee, Annery G. Garcia‐Marcinkiewicz   +17 more
wiley   +1 more source

A Multidisciplinary Approach to the Anesthetic Management of Patients With Duchenne Muscular Dystrophy

Pediatric Pulmonology, Volume 61, Issue 10, October 2026.
ABSTRACT Duchenne muscular dystrophy (DMD) is an inherited neuromuscular disorder with multisystem involvement that causes progressive muscular weakness and cardiorespiratory dysfunction. The first comprehensive recommendations regarding anesthetic management are now almost 20 years old and, in the interval, DMD care has evolved.
Fabrizio Racca, Elena Conti, Giulia Racca, Luigi Barberis, David J. Birnkrant   +4 more
wiley   +1 more source

Evaluation of the effects of a single bolus of cisatracurium as part of an anesthetic protocol in cats undergoing orthopedic surgery

BMC Veterinary Research
Non-depolarizing neuromuscular blocking agents (NMBAs) are commonly used in human anesthesia but remain uncommon in veterinary medicine. This study evaluated the effects of 0.5 mg/kg cisatracurium IV on muscle relaxation, cardiovascular variables and ...
Claudia Interlandi, Marco Tabbì, Nicola Iannelli, Diego Iannelli, Giuseppe Barillaro, Viola Zappone, Simona Di Pietro, Francesco Macrì   +7 more
doaj   +1 more source

Incidence of postoperative residual neuromuscular blockade: a prospective observational study

Colombian Journal of Anesthesiology
Introduction: The use of non-depolarizing neuromuscular blockers (ND-NMB) is essential in anesthetic management as it improves ventilation conditions, airway management, and surgical conditions.
Diego Luis Vélez-Agudelo, Santiago Andrés Salazar-Cortés, Alex García, Fabián David Casas-Arroyave   +3 more
doaj   +1 more source

Mitochondria‐Targeted Nanotherapies in Aging Neurodegenerative Disorders: Emerging Prospects and Clinical Potential

Advanced Healthcare Materials, Volume 15, Issue 36, 25 September 2026.
Mitochondria‐targeted nanotherapies emerge as a promising strategy for combating aging‐associated neurodegenerative disorders (NDs) by restoring mitochondrial function, reducing oxidative stress, and improving neuronal survival. Recent advances in nanotechnology, therapeutic delivery, and translational research are highlighted, providing insights into ...
Dnyandev G. Gadhave, Ashish B. Jadhav, Nitin B. Waghamode, Shubham Khot, Rajiya Khan, Ravi Hole, Shankar M. Dhobale, Manoj Aswar, Keshav Raj Paudel   +8 more
wiley   +1 more source

Use of Sugammadex after Neostigmine Incomplete Reversal of Rocuronium-Induced Neuromuscular Blockade

, 2012
SummaryBackground and objectivesNeuromuscular blockers (NMB) have been used for more than half of a century in anesthesia and have always been a challenge for anesthesiologists.
Silva, Enis Donizetti, Moore Peceguini, Lilian Akemi, Lilian Akemi Moore Peceguini, Enis Donizetti Silva, Claudia Marquez Simões, Cássio Campelo de Menezes, Simoes, Claudia Marquez, de Menezes, Cassio Campelo   +7 more
core   +1 more source

MXene Bioinks for 3D Bioprinting: Design and Translation

Small, Volume 22, Issue 50, 7 September 2026.
This study establishes a comprehensive framework for MXene‐based bioinks in 3D bioprinting, highlighting the interplay between rheological engineering and electroactive hydrogels. By optimizing electrical percolation and mediated signaling, these formulations drive tissue‐specific biological outcomes and accelerated regeneration.
Begüm Sarac, Seydanur Yücer, Fatih Ciftci   +2 more
wiley   +1 more source

Effect of propofol in rat diaphragm phrenic nerve preparation and its interaction with non-depolarizing neuromuscular blocker drugs SICAN DIYAFRAM FRENIK SINIR PREPARATINDA PROPOFOLUN ETKISI VE NON-DEPOLARIZAN NOROMUSKULER BLOKER DROGLARLA ETKILESIMI

, 1996
In the recently available 'Diprivan' preparation, propofol does not contain Cremophor EL vehicle. In clinical use, there are contradictory results in the neuromuscular blocking effect of propofol without Cremophor EL.
DENİZBAŞI ALTINOK, ARZU, ÖZYAZGAN, Sibel, Ozuner, Z.   +2 more
core